10 No. 3 ANHLLR 16Andrews Health Law Litigation Reporter (Approx. 2 pages)
10 No. 3 Andrews Health L. Litig. Rep. 16
Andrews Health Law Litigation Reporter
September 13, 2002
Copyright (c) 2002 Andrews Publications
BIOVAIL, ELAN SETTLE FTC CHARGES OVER MARKETING AGREEMENT FOR GENERIC ADALAT
In re Biovail Corp. and Elan Corp.
Biovail Corp. and Elan Corp. have agreed to settle Federal Trade Commission charges that they hampered competition in the U.S. market for a generic version of Bayer AG's hypertension medication Adalat. The FTC said this was the first time it took...